← Back to Clinical Trials
Recruiting NCT06910995

NCT06910995 Augmented Reality Location-Based Games on Physical Activity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06910995
Status Recruiting
Phase
Sponsor Taipei Medical University
Condition Physical Activity
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2025-02-24
Primary Completion 2025-07-31

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AR location-based game

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2025-02-24 with a primary completion date of 2025-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to examine the effects of an augmented reality location-based game intervention on behavioral and psychological factors related to physical activity among middle-aged and older adults. The study adopts a quasi-experimental design, targeting community-dwelling individuals aged 40-59 or 60 and above, who engage in sedentary work patterns exceeding 6 hours daily. Recruitment is scheduled to commence in February 2025 at the Xinyi Health Service Center in Taipei City. Participants will be assigned to either the experimental group or the control group based on enrollment timing. A minimum of 41 participants will be recruited, divided into two experimental groups and two control groups. The experimental group will participate in an augmented reality location-based game featuring different step count goals every two weeks, daily step count reporting, and goal achievement encouragement. The control group will maintain their usual routines without any intervention. The intervention will last for 8 weeks. Research instruments will include a basic demographic questionnaire, the short-form Taiwan Physical Activity Questionnaire, the Exercise Self-Efficacy Scale, the Exercise Motivation and Barriers Scale, blood pressure measurements, and the Quality of Life Scale.

Eligibility Criteria

Inclusion Criteria: 1. Meet one of the following conditions: middle-aged to senior citizens aged 40 to 59 years old or senior citizens aged 60 years old or older who work more than 6 hours a day in a sedentary lifestyle 2. Able to walk independently without the use of aids. 3. Have a smart phone with an application (Pikmin Bloom) that can be installed and can access the Internet and GPS. Exclusion Criteria: 1. Patients who have been diagnosed by a doctor as suffering from dementia, mental illness or major diseases. 2. Those who are unable to do intense exercise as mentioned in the medical advice. 3. Those who cannot go out for long time, such as family caregivers. 4. Those who have regular exercise habits: average daily steps over 5,000 steps or 30 minutes of leisure-type physical activity more than 3 times a week. 5. Those who will not use the AR adaptive game (Pikmin Bloom) at the end of the 2-day test period.

Contact & Investigator

Central Contact

Hsin-Yen Yen, PhD

✉ kenji@tmu.edu.tw

📞 +886-2-27361661

Frequently Asked Questions

Who can join the NCT06910995 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06910995 currently recruiting?

Yes, NCT06910995 is actively recruiting participants. Contact the research team at kenji@tmu.edu.tw for enrollment information.

Where is the NCT06910995 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06910995 clinical trial?

NCT06910995 is sponsored by Taipei Medical University. The trial plans to enroll 200 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology